Bharat Biotech’s Nasal Vaccine iNCOVACC To Cost Rs 800: Sources
The iNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein.
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Drugs Controller General of India
COVID-19 Vaccine Update: Clinical Trials For Third Dose Of Covaxin Allowed
New Delhi: An expert panel of Drugs Controller General of India (DCGI) has permitted Bharat Biotech to administer a third dose of its COVID-19 vaccine Covaxin to a select group of volunteers in its clinical trials, PTI reported quoting…
COVID-19 Vaccine: Sputnik V Finally Gets DCGI Nod For Phase 2/3 Trials In India
New Delhi: Having refused permission earlier, the Drugs Controller General of India (DCGI) has now allowed Dr Reddy’s to conduct phase 2/3 clinical human trials of Russia’s Sputnik V vaccine candidate.
“This will be a multi-centre and…
All You Need to Know About India’s First Paper-Strip COVID Test Named After Satyajit…
New Delhi: An indigenous paper-strip COVID-19 diagnostic test, named after one of India’s most famous fictitious detectives 'FELUDA', recently received approval from the Drugs Controller General of India for a commercial rollout.
This test…
Panel Recomends Phase II & III Of Human Clinical Trials Of Oxford Vaccine Candidate
New Delhi: There is a recommendation to grant permission to the Serum Institute of India (SII) to conduct the second and third phases of human clinical trials of the Oxford vaccine candidate, NDTV reported.
The recommendations of the…
Drug Regulator Okays Restrictive Use Of Itolizumab To Treat COVID Patients
New Delhi: India’s drug regulator has approved Itolizumab, a drug used to cure skin ailment psoriasis, for “restricted emergency use” to treat COVID-19 patients with moderate to severe acute respiratory distress.
Considering the unmet…
COVID Crisis: Remdesivir Hits Drug Regulator Hurdle In India
New Delhi: Even as COVID-19 cases are soaring in India, patients in the country are still to get Remdesivir, an experimental drug which has shown promise in treatment of coronavirus in other countries.
This is because the Drugs Controller…